Literature DB >> 11373340

Obstructive nephropathy in the mouse: progressive fibrosis correlates with tubulointerstitial chemokine expression and accumulation of CC chemokine receptor 2- and 5-positive leukocytes.

Volker Vielhauer1, Hans-Joachim Anders1, Matthias Mack1, Josef Cihak2, Frank Strutz3, Manfred Stangassinger2, Bruno Luckow1, Hermann-Josef Gröne4, Detlef Schlöndorff1.   

Abstract

The infiltration of leukocytes plays a major role in mediating tubulointerstitial inflammation and fibrosis in chronic renal disease. CC chemokines participate in leukocyte migration and infiltration into inflamed renal tissue. Because CC chemokine-directed leukocyte migration is mediated by target cell expression of a group of CC chemokine receptors, this study examined the expression of CC chemokines and their receptors during initiation of tubulointerstitial fibrosis after unilateral ureteral obstruction in C57BL/6 mice. Obstructed kidneys developed hydronephrosis, tubular cell damage, interstitial inflammation, and fibrosis. From days 2 to 10, a progressive interstitial influx of F4/80+ macrophages and CD3+ lymphocytes occurred (macrophages, 4-fold; lymphocytes, 20-fold at day 10, compared with contralateral control kidneys). In parallel, the number of activated fibroblast-specific protein 1+ fibroblasts and interstitial collagen IV accumulation increased from days 2 to 10. The mRNA expression of CC chemokines (predominantly monocyte chemoattractant protein-1 [MCP-1]/CCL2, RANTES/CCL5) and their receptors CCR1, CCR2, CCR5 increased progressively from days 2 to 10. By in situ hybridization, a prominent interstitial mRNA expression of MCP-1 and RANTES and their receptors CCR2 and CCR5 localized to interstitial mononuclear cell infiltrates. MCP-1 and RANTES expression was also seen in tubular epithelial cells. Fluorescence-activated cell sorter analysis of single-cell suspensions from obstructed kidneys revealed a prominent expression of CCR2 and CCR5 by infiltrating macrophages, whereas most lymphocytes expressed CCR5 only. These data demonstrate an increased expression of MCP-1/CCL2 and RANTES/CCL5 at sites of tubulointerstitial damage and progressive fibrosis during unilateral ureteral obstruction that correlates with simultaneous accumulation of interstitial macrophages and T lymphocytes expressing the respective surface receptors CCR2 and CCR5. The chemokine receptor-mediated leukocyte influx into the tubulointerstitium could offer a new potential target for therapeutic intervention in progressive renal tubulointerstitial fibrosis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11373340     DOI: 10.1681/ASN.V1261173

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  59 in total

1.  Fibroblast expression of an IκB dominant-negative transgene attenuates renal fibrosis.

Authors:  Tsutomu Inoue; Tsuneo Takenaka; Matsuhiko Hayashi; Toshiaki Monkawa; Jun Yoshino; Kouji Shimoda; Eric G Neilson; Hiromichi Suzuki; Hirokazu Okada
Journal:  J Am Soc Nephrol       Date:  2010-09-16       Impact factor: 10.121

2.  Alphav beta6 integrin regulates renal fibrosis and inflammation in Alport mouse.

Authors:  Kyungmin Hahm; Matvey E Lukashev; Yi Luo; William J Yang; Brian M Dolinski; Paul H Weinreb; Kenneth J Simon; Li Chun Wang; Diane R Leone; Roy R Lobb; Donald J McCrann; Normand E Allaire; Gerald S Horan; Agnes Fogo; Raghu Kalluri; Charles F Shield; Dean Sheppard; Humphrey A Gardner; Shelia M Violette
Journal:  Am J Pathol       Date:  2007-01       Impact factor: 4.307

3.  A chemokine receptor CCR-1 antagonist reduces renal fibrosis after unilateral ureter ligation.

Authors:  Hans-Joachim Anders; Volker Vielhauer; Michael Frink; Yvonne Linde; Clemens D Cohen; Simone M Blattner; Matthias Kretzler; Frank Strutz; Matthias Mack; Hermann-Josef Gröne; James Onuffer; Richard Horuk; Peter J Nelson; Detlef Schlöndorff
Journal:  J Clin Invest       Date:  2002-01       Impact factor: 14.808

4.  Early differential expression of oncostatin M in obstructive nephropathy.

Authors:  Wafa M Elbjeirami; Luan D Truong; Ahmad Tawil; Wansheng Wang; Sara Dawson; Hui Y Lan; Ping Zhang; Gabriela E Garcia; C Wayne Smith
Journal:  J Interferon Cytokine Res       Date:  2010-07       Impact factor: 2.607

5.  Lysophosphatidic acid signaling through its receptor initiates profibrotic epithelial cell fibroblast communication mediated by epithelial cell derived connective tissue growth factor.

Authors:  Norihiko Sakai; Jerold Chun; Jeremy S Duffield; David Lagares; Takashi Wada; Andrew D Luster; Andrew M Tager
Journal:  Kidney Int       Date:  2016-12-04       Impact factor: 10.612

6.  Tubular Dickkopf-3 promotes the development of renal atrophy and fibrosis.

Authors:  Giuseppina Federico; Michael Meister; Daniel Mathow; Gunnar H Heine; Gerhard Moldenhauer; Zoran V Popovic; Viola Nordström; Annette Kopp-Schneider; Thomas Hielscher; Peter J Nelson; Franz Schaefer; Stefan Porubsky; Danilo Fliser; Bernd Arnold; Hermann-Josef Gröne
Journal:  JCI Insight       Date:  2016-01-21

Review 7.  Obstructive nephropathy: insights from genetically engineered animals.

Authors:  Jean-Loup Bascands; Joost P Schanstra
Journal:  Kidney Int       Date:  2005-09       Impact factor: 10.612

8.  Epithelial cell TGFβ signaling induces acute tubular injury and interstitial inflammation.

Authors:  Madeleine E Gentle; Shaolin Shi; Ilse Daehn; Taoran Zhang; Haiying Qi; Liping Yu; Vivette D D'Agati; Detlef O Schlondorff; Erwin P Bottinger
Journal:  J Am Soc Nephrol       Date:  2013-03-28       Impact factor: 10.121

9.  Role of inflammation in túbulo-interstitial damage associated to obstructive nephropathy.

Authors:  María T Grande; Fernando Pérez-Barriocanal; José M López-Novoa
Journal:  J Inflamm (Lond)       Date:  2010-04-22       Impact factor: 4.981

10.  Efficient renal recruitment of macrophages and T cells in mice lacking the duffy antigen/receptor for chemokines.

Authors:  Volker Vielhauer; Ramanjaneyulu Allam; Maja T Lindenmeyer; Clemens D Cohen; Dan Draganovici; Jana Mandelbaum; Nuru Eltrich; Peter J Nelson; Hans-Joachim Anders; Monika Pruenster; Antal Rot; Detlef Schlöndorff; Stephan Segerer
Journal:  Am J Pathol       Date:  2009-06-04       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.